These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 7695216)
1. Evidence for lipid regression in humans in vivo performed by 123iodine-low-density lipoprotein scintiscanning. Pirich C; Sinzinger H Ann N Y Acad Sci; 1995 Jan; 748():613-21. PubMed ID: 7695216 [TBL] [Abstract][Full Text] [Related]
2. Aspirin abolishes the decreased low-density lipoprotein (LDL) entry into the rabbit arterial wall induced by the calcium channel blocker isradipine. Sinzinger H; Virgolini I; O'Grady J; Keiler A; Lupattelli G; Angelberger P; Molinari E Eicosanoids; 1992; 5(1):13-6. PubMed ID: 1419074 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandins and arterial wall lipid metabolism--in vitro, ex-vivo and in-vivo radioisotopic studies. Sinzinger H; Rogatti W J Physiol Pharmacol; 1994 Mar; 45(1):27-40. PubMed ID: 8043908 [TBL] [Abstract][Full Text] [Related]
11. Isradipine decreases the entry of radioiodine-labelled low-density lipoproteins into the arterial wall. Pirich C; Fitscha P; Schmid P; Sinzinger H Blood Press Suppl; 1994; 1():70-4. PubMed ID: 8205306 [TBL] [Abstract][Full Text] [Related]
12. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. Schwenke DC; Carew TE Arteriosclerosis; 1989; 9(6):908-18. PubMed ID: 2590068 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E1 increases binding of 123I-low-density lipoprotein to the human liver in vivo. Sinzinger H; Kritz H; Virgolini I; Schmid P; Rogatti W Eur J Clin Pharmacol; 1996; 49(6):515-20. PubMed ID: 8706779 [TBL] [Abstract][Full Text] [Related]
14. Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage. Virgolini I; Angelberger P; O'Grady J; Sinzinger H Eur J Nucl Med; 1991; 18(12):944-7. PubMed ID: 1778203 [TBL] [Abstract][Full Text] [Related]
15. Arterial wall rather than platelets is responsible for diminished thrombogenicity during isradipine therapy. Sinzinger H; Keiler A; O'Grady J J Cardiovasc Pharmacol; 1995 Mar; 25(3):453-8. PubMed ID: 7769812 [TBL] [Abstract][Full Text] [Related]